Slideshow

Interesting T2DM: Weight Loss Device & Meds Update

Our October list of news and research includes FDA approval of a new weight loss device, a comparison of canagliflozin & glimepiride, and more.

We present a selection of interesting news and research for the month of October focusing on type 2 diabetes. See the slide legends for links to the article summaries.Be on the lookout for our regular Interesting Endocrinology series later this month, which will cover type 1 diabetes and other endocrine disorders. 

Related Videos
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
© 2025 MJH Life Sciences

All rights reserved.